AI pre-screen
Possible
66/100
Meets core inclusion criteria; a few items to confirm at the screening visit.
Screening detail
Meets criteria
Meets DSM-5-TR criteria for current MDD
Age within 18-74
To confirm
MADRS severity to confirm at screening
Step 2 · Message Yara
Write them from the thread on this page. We do not email applicants a calendar or ask them to pick a time.
AI-assisted decision support. A qualified team member must review and decide.
Messages
Applied Aug 15 · via Website
Hi Yara, thanks for your interest. I've noted what happens next; let me know if anything is unclear.
Is travel to the site reimbursed?
Reminder: your followup visit is on 2026-09-22 12:00 at Northwind Clinical Research. Showing up is the key step - reply here if anything's in the way.
Contact & details
Applied to
Azetukalner Open-Label Extension in Major Depressive Disorder (X-NOVA-OLE)
NCT06922110
Stage advances from what you do. Accepting marks them likely eligible; booking a visit moves them to screening.
Patient portal
Give Yara B. a private page to follow their own status, see what's outstanding, and message you back , no account signup. The link and a one-time password are sent straight to their message thread.
Notes team-only
Type @ to pull a teammate into this thread instead of CC-ing them on an email.
No notes yet. Jot context only your team sees.
Tasks
No to-dos yet.
Screening answers
Can travel to the study site
Yes
Currently in another trial
No
Pregnant / planning pregnancy
No
Can give own consent
Yes
Documents
Timeline
application received
2026-08-15 03:34 · you
ready for study-team review
2026-08-15 03:34 · you
accepted - likely eligible
2026-08-15 03:34 · you